[PAR] YoY Quarter Result on 31-Dec-2018 [#Q2]

Stock
[PAR] Paradigm Biopharmaceuticals Limited
Announcement Date
30-Dec-2018
Financial Year
2019
Quarter
31-Dec-2018 [#Q2]
Profit Trend
QoQ- -68.13%
YoY- -23.15%
Quarter Report
PAR's Result
PAR's Financial Summary
View:
Show?
Quarter Result
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Revenue 45 0 826 28 22 58 46 -0.36%
PBT -26,985 -20,730 -5,104 -4,400 -3,573 -2,818 -1,423 63.22%
Tax 0 -0 826 0 0 0 0 -
NP -26,985 -20,730 -5,104 -4,400 -3,573 -2,818 -1,423 63.22%
Tax Rate - - - - - - - -
Total Cost 27,030 20,730 5,930 4,428 3,596 2,876 1,469 62.40%
Ratio Analysis
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
NP Margin -59,701.41 0.00 -617.95 -15,637.06 -15,998.41 -4,891.80 -3,086.06 63.77%
Per Share
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
EPS -0.11 -0.09 -0.03 -0.03 -0.03 -0.03 -0.02 32.82%
EPS Diluted -0.11 -0.09 -0.03 -0.03 -0.03 -0.03 -0.02 32.82%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.